Welcome to our dedicated page for HUNTINGTON BANCSHARES /MD/ SEC filings (Ticker: HBANP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HUNTINGTON BANCSHARES /MD/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HUNTINGTON BANCSHARES /MD/'s regulatory disclosures and financial reporting.
Huntington Bancshares Incorporated (NASDAQ: HBAN) filed a Form 8-K dated July 14, 2025 to disclose two material items.
- Item 2.02 – Preliminary Q2 2025 results: The company announced that it has released preliminary second-quarter financial results for the period ended June 30, 2025. Detailed figures were not included in the 8-K; full results are scheduled for release on Friday, July 18, 2025. A copy of the preliminary results press release is furnished as Exhibit 99.1, and an investor presentation is furnished as Exhibit 99.2. Management expressly states that these furnished materials are not deemed “filed” for liability purposes under the Exchange Act.
- Item 7.01 – Regulation FD / Merger announcement: On July 13, 2025, Huntington executed an Agreement and Plan of Merger under which Veritex Holdings, Inc. will merge with and into Huntington, with Huntington continuing as the surviving entity. The joint press release (Exhibit 99.1) and investor presentation (Exhibit 99.2) summarize the proposed transaction; specific consideration terms are not disclosed within the filing. Completion is subject to customary conditions, including regulatory clearances and approval by Veritex shareholders.
The filing lists Huntington’s existing listed securities (common stock HBAN and three series of preferred shares: HBANP, HBANM, HBANL) and affirms that the company is not an emerging growth company. Extensive forward-looking-statement language outlines economic and regulatory risks, integration challenges, shareholder approval requirements, and potential dilution from new share issuance.
The company will file an S-4 registration statement containing a proxy statement/prospectus for Veritex shareholders. Investors are urged to read these materials when available.
Key takeaways for investors:
- Huntington is pursuing a strategic expansion through the agreed merger with Veritex; if completed, the deal could enlarge the bank’s footprint and customer base.
- Financial details of both the acquisition and preliminary Q2 results remain undisclosed in this 8-K, leaving valuation and capital impact questions open until subsequent filings.
- The transaction carries customary regulatory, shareholder, and integration risks expressly highlighted in the forward-looking-statement section.